Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
62.99
-0.32 (-0.51%)
At close: Oct 30, 2026, 4:00 PM EDT
63.15
+0.16 (0.25%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Cytokinetics Market Cap
Cytokinetics has a market cap or net worth of $8.76 billion as of October 30, 2026. It is the 2,339th most valuable company in the world and the 831st biggest in the United States. Its market cap has increased by 18.06% in one year.
Market Cap
8.76B
Enterprise Value
9.02B
1-Year Change
18.06%
Global Rank
Country Rank
#831 United States
Category
ChartMarket Cap Chart
Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $8.76B, an increase of 1,988.50%. That is a compound annual growth rate of 14.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 8.76B | 12.72% |
| Dec 31, 2025 | 7.77B | 39.94% |
| Dec 31, 2024 | 5.55B | -32.19% |
| Dec 29, 2023 | 8.19B | 88.80% |
| Dec 30, 2022 | 4.34B | 13.41% |
| Dec 31, 2021 | 3.82B | 159.95% |
| Dec 31, 2020 | 1.47B | 134.61% |
| Dec 31, 2019 | 626.90M | 81.29% |
| Dec 31, 2018 | 345.80M | -21.27% |
| Dec 29, 2017 | 439.20M | -10.79% |
| Dec 30, 2016 | 492.30M | 21.17% |
| Dec 31, 2015 | 406.30M | 38.57% |
| Dec 31, 2014 | 293.20M | 52.87% |
| Dec 31, 2013 | 191.80M | 104.04% |
| Dec 31, 2012 | 94.00M | 35.45% |
| Dec 30, 2011 | 69.40M | -49.60% |
| Dec 31, 2010 | 137.70M | -22.34% |
| Dec 31, 2009 | 177.30M | 25.83% |
| Dec 31, 2008 | 140.90M | -39.40% |
| Dec 31, 2007 | 232.50M | -17.84% |
| Dec 29, 2006 | 283.00M | 51.01% |
| Dec 30, 2005 | 187.40M | -35.49% |
| Dec 31, 2004 | 290.50M | -30.72% |
| Apr 30, 2004 | 419.30M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Krystal Biotech | 9.84B |
| Vaxcyte | 9.76B |
| Caris Life Sciences | 9.70B |
| Twist Bioscience | 9.58B |
| Protagonist Therapeutics | 9.37B |
| Spyre Therapeutics | 9.02B |
| ImmunityBio | 8.79B |
| Corcept Therapeutics | 8.77B |